PharmaCyte Biotech Inc (PMCB)

[Mens et Manus]

My take:

1. Trial design is finalized but not locations. My guess sites waiting for IND approval before commitment can be finalized. Still impressive list of sites.

2. # of patients may be less if results are extremely successful and thus trial could be ended early and PMCB applies for accelerated approval.